Precision Oncology: Translating Discovery to the Clinic | EK45



Sessions

Targeted EGFR/HER2 Therapy to Overcome the Blood-Brain Barrier

Speaker(s):

Defining Mechanisms of Resistance to KRASG12C Inhibitors

Speaker(s):

Mechanisms of Resistance to Endocrine Therapy and CDK4/6 Inhibitors in ER+ Breast Cancer

Speaker(s):

Meet the Editors Roundtable iconMeet the Editors Roundtable

Preview Available

Meet the Editors Roundtable

Speaker(s):

Driving Precision Medicine through Clinical Computational Oncology

Speaker(s):

Emerging Technologies II iconEmerging Technologies II

Preview Available

Emerging Technologies II

Co-Chair(s):

Organotypic Modeling of Cancer and Immune Cell Dynamics

Speaker(s):

Inferring and Making Sense Out of Cancer Cell Phylogenies

Speaker(s):
  • Nir Yosef, PhD, University of California, Berkeley

Targeted Protein Degradation- A New Approach for Challenging Targets

Speaker(s):

Short Talk: MLL-Menin Inhibition Reverses Pre-leukemic Progenitor Self-renewal in NPM1 Mutant AML

Speaker(s):